Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection

about

Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection

Item

http://www.wikidata.org/entity/Q57474736

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 11 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Rituximab, plasma exchange and ...... ve antibody-mediated rejection

@en

Rituximab, plasma exchange and ...... ve antibody-mediated rejection

@nl

type

Item

label

Rituximab, plasma exchange and ...... ve antibody-mediated rejection

@en

Rituximab, plasma exchange and ...... ve antibody-mediated rejection

@nl

prefLabel

Rituximab, plasma exchange and ...... ve antibody-mediated rejection

@en

Rituximab, plasma exchange and ...... ve antibody-mediated rejection

@nl

P1476

Rituximab, plasma exchange and ...... ve antibody-mediated rejection

@en

P2093

David Cucchiari

http://www.w3.org/2001/XMLSchema#string

Erika De Sousa-Amorim

http://www.w3.org/2001/XMLSchema#string

Federico Oppenheimer

http://www.w3.org/2001/XMLSchema#string

Frederic Cofán

http://www.w3.org/2001/XMLSchema#string

Gastón J Piñeiro

http://www.w3.org/2001/XMLSchema#string

Ignacio Revuelta

http://www.w3.org/2001/XMLSchema#string

Josep M Campistol

http://www.w3.org/2001/XMLSchema#string

Manel Solé

http://www.w3.org/2001/XMLSchema#string

Miguel Lozano

http://www.w3.org/2001/XMLSchema#string

Pedro Ventura-Aguiar

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic tests 4: likelihood ratios

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

The histology of kidney transplant failure: a long-term follow-up study.

Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts.

Focal C4d+ in renal allografts is associated with the presence of donor-specific antibodies and decreased allograft survival.

Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure.

Transplant glomerulopathy: clinical course and factors relating to graft survival.

Better understanding of transplant glomerulopathy secondary to chronic antibody-mediated rejection.

Current outcomes of chronic active antibody mediated rejection - A large single center retrospective review using the updated BANFF 2013 criteria.

P2888

s12882-018-1057-4

P304

261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12882-018-1057-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1107561268

http://www.w3.org/2001/XMLSchema#string

P698

30309322

http://www.w3.org/2001/XMLSchema#string

P921

nephrology

P932

6182805

http://www.w3.org/2001/XMLSchema#string